Real-World Use – Isavuconazole at a Large Academic Medical Center

Patients given ISV following triazole prophylaxis, those undergoing TDM, and those with an identified fungal pathogen had increased odds of complete or partial response, but this did not reach statistical significance (Figure 2).

also in 111,027 other papers